Image

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.

Studying Venetoclax effects on CLL treatment with BTK inhibitors.

Recruiting
18 years and older
All
Phase 2

The study looks at how well the drug venetoclax works when added to another treatment called a covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for people with *Chronic Lymphocytic Leukemia* (CLL). CLL is a type of cancer that affects blood and bone marrow. The goal is to see if this combination can make the cancer disappear so much that it can’t be measured in the blood anymore. This is called *undetectable measurable residual disease* (uMRD). If successful, patients might have an *off-treatment period*, meaning they could stop taking the medication for a while. To join the study, patients must have been on a stable dose of cBTKi for at least six months and show improvement. They must also be healthy enough based on specific criteria. However, people with certain medical conditions or who have used similar medications before may not qualify.

  • Study requires a stable cBTKi dose for 6 months before joining.
  • Participants must have specific health criteria met.
  • Some past medical conditions may prevent joining the study.
Study details
    Chronic Lymphocytic Leukemia

NCT06524375

Genentech, Inc.

15 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.